(Q38802151)

6 September 2017

1 reference

title

Non-viral delivery of genome-editing nucleases for gene therapy (English)

1 reference

6 September 2017

0 references

M Wang

1

1 reference

PubMed ID

27797355

6 September 2017

Z A Glass

series ordinal

2

1 reference

PubMed ID

27797355

6 September 2017

Q Xu

series ordinal

3

1 reference

6 September 2017

31 October 2016

1 reference

6 September 2017

1 reference

6 September 2017

24

1 reference

6 September 2017

3

1 reference

6 September 2017

144-150

1 reference

https://scigraph.springernature.com/pub.10.1038/gt.2016.72

6 September 2017

0 references

cites work

Therapeutic genome editing: prospects and challenges

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Genome engineering with targetable nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Genome editing at the crossroads of delivery, specificity, and fidelity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Multiplex Genome-Edited T-cell Manufacturing Platform for "Off-the-Shelf" Adoptive T-cell Immunotherapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

CRISPR-Cas: From the Bacterial Adaptive Immune System to a Versatile Tool for Genome Engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Genome editing. The new frontier of genome engineering with CRISPR-Cas9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Genome-scale CRISPR-Cas9 knockout screening in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Multiplex genome engineering using CRISPR/Cas systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

RNA-guided human genome engineering via Cas9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Development and applications of CRISPR-Cas9 for genome engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Cas9 as a versatile tool for engineering biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

CRISPR-Cas systems for editing, regulating and targeting genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

The democratization of gene editing: Insights from site-specific cleavage and double-strand break repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Delivering the goods: scientists seek a way to make CRISPR-Cas gene editing more targeted.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Engineering Delivery Vehicles for Genome Editing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Delivery and Specificity of CRISPR-Cas9 Genome Editing Technologies for Human Gene Therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Challenges in CRISPR/CAS9 Delivery: Potential Roles of Nonviral Vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Current and future delivery systems for engineered nucleases: ZFN, TALEN and RGEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Construction and characterization of adenoviral vectors for the delivery of TALENs into human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

In vivo genome editing restores haemostasis in a mouse model of haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Lentivirus pre-packed with Cas9 protein for safer gene editing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Targeted genome editing by lentiviral protein transduction of zinc-finger and TAL-effector nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Engineered Viruses as Genome Editing Devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

In vivo genome editing using Staphylococcus aureus Cas9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Generation of knock-in primary human T cells using Cas9 ribonucleoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Hydrodynamic gene delivery: its principles and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Tyrosinemia type I--diagnostic issues and prenatal diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Targeted genome engineering in human induced pluripotent stem cells by penetrating TALENs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Cell-penetrating peptide-mediated delivery of TALEN proteins via bioconjugation for genome engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Therapeutic applications of the cell-penetrating HIV-1 Tat peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Non-viral vectors for gene-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Tailoring nanocarriers for intracellular protein delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Nanocarriers as an emerging platform for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Protein drug stability: a formulation challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Highly efficient endogenous human gene correction using designed zinc-finger nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Zinc-finger nucleases as a novel therapeutic strategy for targeting hepatitis B virus DNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Enhanced intracellular siRNA delivery using bioreducible lipid-like nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Combinatorial library strategies for synthesis of cationic lipid-like nanoparticles and their potential medical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Reactive oxygen species-responsive protein modification and its intracellular delivery for targeted cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Combinatorially designed lipid-like nanoparticles for intracellular delivery of cytotoxic protein for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

A combinatorial library of unsaturated lipidoids for efficient intracellular gene delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Combinatorial library of lipidoids for in vitro DNA delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

DOPE facilitates quaternized lipidoids (QLDs) for in vitro DNA delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Self-assembled DNA nanoclews for the efficient delivery of CRISPR-Cas9 for genome editing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

Genome engineering: the next genomic revolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

7 January 2021

inferred from DOI database lookup

In vivo genome editing using nuclease-encoding mRNA corrects SP-B deficiency

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

7 January 2021

inferred from DOI database lookup

Efficient intracellular delivery of native proteins

1 reference

https://api.crossref.org/works/10.1038%2FGT.2016.72

7 January 2021

inferred from DOI database lookup

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27797355

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/GT.2016.72

1 reference

6 September 2017

1 reference

PubMed ID

27797355